GLP-1 and Muscle Loss
How to Protect Muscle with Protein, Strength Training, and Smarter Monitoring

This audiobook is narrated by an AI Voice.
In the largest clinical trial run on semaglutide, close to forty-five percent of the weight participants lost, measured directly on body scans rather than the scale, was lean muscle — roughly thirteen percent of their starting muscle mass, on average. A separate large trial of tirzepatide found the same pattern. The scale can't tell you what you actually lost. GLP-1 drugs suppress appetite and slow digestion — they don't distinguish which tissue gets burned to cover the resulting calorie deficit.

This isn't a reason to avoid these drugs. It's a mechanism most prescribing appointments never mention, buried under nausea checklists and hydration reminders. The reason the body burns muscle instead of protecting it has a name — anabolic resistance — and it gets worse with age, exactly when these drugs get prescribed most. The same appetite suppression that makes food noise disappear also makes it physically harder to eat enough protein to fight back.

This audiobook covers what actually protects muscle through rapid GLP-1 weight loss: the specific protein target and how to hit it when a full meal feels impossible, the kind of strength training that does more than any amount of cardio, and how to read a body composition scan instead of trusting the number on the scale alone. It also covers what happens after the drug — how the shape of muscle loss changes what comes back if the weight returns.